Clinical Research
We promote Innovation
Clinical Research and Innovation
The Central Unit for Clinical Research and Innovation (UCICi) is an IMED initiative that was created in order to integrate all activities derived from clinical research and innovation of the Group's hospitals under the umbrella of a ‘one-stop shop’ as a single point of contact.
The unit's mission focuses on facilitating and promoting quality research and encouraging and fostering a culture of innovation.
Moreover, it provides a response to promoters, CROs and researchers in relation to the technical, administrative, logistical and legal needs to carry out clinical trials. Its specific functions include:
-
Recruitment of Promoters interested in developing a clinical trial or observational study.
-
Personalised advice to the Promoter in the search of IPs and collaborators for the development of the clinical trial or observational study.
-
Intermediation between the promoter, the researcher and the centre
. -
Intermediation between researcher and CEIm.
-
Coordination between the clinical services involved.
-
Management of contracts. Time optimisation.
-
Financial management of the agreements. Compensation to the staff involved.
-
Advice for the development of independent clinical research.
-
Regulatory and legal advice.
Suitability of Facilities' Managment
At IMED Hospitales, the person authorised to sign the document of Suitability of Facilities is the Medical Director.
The promoter/CRO can request the signature of this document by filling the following form:
Management of Contracts
Contracts signed with IMED Hospitales will be managed through the form: Processing Form .
At IMED Hospitales we use our own models.
Once the contract has been concluded between the parties, it will become effective when the clinical trial is authorised by the The Spanish Agency of Medicines and Medical Devices and/or has a pertinent approval of the Ethics Committee in each case.
Once the contract has been concluded between the parties, it will become effective when the clinical trial is authorised by the The Spanish Agency of Medicines and Medical Devices and/or has a pertinent approval of the Ethics Committee in each case.
Clinical Trial Patients
How to get into a Clinical Trial?
It is usually the doctor who proposes to the patient to take part in a clinical trial and gives information about the steps to follow. In the event that the patient knows that there is a clinical trial that could be beneficial to his/her condition, it would still be the doctor who refers the patient into it; and it would be the doctor who could provide more information on a subject matter.
In Spain, the public database REEC ( Spanish Clinical Trials Register ) has got information on all clinical trials performed in Spain from 2013 untill the present moment, and allows us to to know in which areas or pathologies these studies are being carried out.
What should you know if you take part in a trial?
Being part of a clinical trial is different from normal medical practice. Your main contact will be with the study team. This team consists of the study doctor, nurses, and other people who work with that doctor.
Visits and procedures, additional laboratory tests and/or a modified treatment plan may be scheduled.
You can suspend your participation at any time and this decision will not affect your regular medical care or other benefits to which you are entitled.
To research the efficacy and safety of a medicine, some participants will receive that medicine and others will receive the standard medicine to treat the disease or a placebo. Before you give your consent to participate, you will be explained how the study works.